Endpoint · market dataGETclinicalintelpulse.theaslangroupllc.com /api/clinical/sponsor-intel ?focus=pipeline+%7C+approvals+%7C+deals+%7C+all+%28default%3A+all%29&lang=en+%7C+es+%7C+fr+%7C+de+%7C+ja+%7C+zh+%7C+ko+%7C+pt+%7C+ar+%7C+hi+%28default%3A+en%29&sponsor=Company+name+%E2%80%94+e.g.+%22Moderna%22+%7C+%22BioNTech%22+%7C+%22Alnylam%22+%7C+%22Vertex+Pharmaceuticals%22+%7C+%22Regeneron%22
Pharma/biotech company pipeline intelligence — full drug pipeline by phase, therapeutic-area coverage, FDA approval history, partnerships, competitive positioning and investment…
Read more
Pharma/biotech company pipeline intelligence — full drug pipeline by phase, therapeutic-area coverage, FDA approval history, partnerships, competitive positioning and investment catalysts for any sponsor. Worldwide. For investor and M&A agents.Overview
Grade?
UNRATED
0 of 30 paid calls toward a letter
Price
$0.20 per call
Paid calls
none yet
delivery unknown until someone pays
More info
Seller?
URL
https://clinicalintelpulse.theaslangroupllc.com/api/clinical/sponsor-intel?focus=pipeline+%7C+approvals+%7C+deals+%7C+all+%28default%3A+all%29&lang=en+%7C+es+%7C+fr+%7C+de+%7C+ja+%7C+zh+%7C+ko+%7C+pt+%7C+ar+%7C+hi+%28default%3A+en%29&sponsor=Company+name+%E2%80%94+e.g.+%22Moderna%22+%7C+%22BioNTech%22+%7C+%22Alnylam%22+%7C+%22Vertex+Pharmaceuticals%22+%7C+%22Regeneron%22
Seen
first 35 days ago · last 15 days ago
53 free handshakes
Payment
Pays through
x402
Offered on?
algorand:wGHE2Pwdvd7S12BL5FaOP20EGYesN73k, Polygon, eip155:143, eip155:196, Arbitrum, eip155:480, eip155:56, Base USDC, eip155:999, Solana, xrpl:0
Listed on?
Polygon, Arbitrum, Base, Solana
Score, from free handshakes onlyweights 2026.09.6
UN
RATED
RATED
0.730 liveness verified, no letter
To a letter · 30 paid calls
0 of 30
Held back by sample size, not by the seller · gap to 1.000 is 0.270: 0.159 uncertain ? + 0.112 short ? · 0.070 to B
| Component | Weight | Measured | Lower bound ? | Adds | Short ? | Uncertain ? | |
|---|---|---|---|---|---|---|---|
| latency p95costs the most it answered as fast as its class |
0.20 | 0.44 | 0.010 | 0.002 | −0.112 | −0.086 | |
| liveness it answered at all |
0.60 | 1.00 | 0.879 | 0.528 | 0 | −0.072 | |
| price stability the price stayed where it was listed |
0.20 | 1.00 | 1.000 | 0.200 | 0 | 0 | |
| Composite | 1.00 | 0.730 | gap to 1.000 = 0.270 · 0.112 short · 0.159 uncertain | 0.730 | −0.112 | −0.159 |
Not measured: correctness · nobody paid; honesty · nobody paid; schema conformance · no answer had a published shape to check
The multiplication, written out
0.200 × 0.010 latency p95
+ 0.600 × 0.879 liveness
+ 0.200 × 1.000 price stability
= 0.730 → UNRATED: 51 of 30 paid calls weights 2026.09.6 · 51 samples · seed cap_01M1A51TG6VW4J35C09J3411QT|2026-08-27T08:11:31.694Z|2026.09.6
Verify it yourself
npx teppi-check https://clinicalintelpulse.theaslangroupllc.com/api/clinical/sponsor-intel?focus=pipeline+%7C+approvals+%7C+deals+%7C+all+%28default%3A+all%29&lang=en+%7C+es+%7C+fr+%7C+de+%7C+ja+%7C+zh+%7C+ko+%7C+pt+%7C+ar+%7C+hi+%28default%3A+en%29&sponsor=Company+name+%E2%80%94+e.g.+%22Moderna%22+%7C+%22BioNTech%22+%7C+%22Alnylam%22+%7C+%22Vertex+Pharmaceuticals%22+%7C+%22Regeneron%22curl -s https://api.teppi.xyz/v1/trust/cap_01M1A51TG6VW4J35C09J3411QT